Chapter 74, SB 200 – Expanding the pharmacist's scope of practice to include initiation of therapy for influenza, strep throat or urinary tract infection, pursuant to a statewide protocol adopted by the collaborative drug therapy management advisory committee

Session2022 Regular Session
Year2022
Enactment Date18 April 2022
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT